Cargando…

Aberrant alternative splicing in breast cancer

Alternative splicing is critical for human gene expression regulation, which plays a determined role in expanding the diversity of functional proteins. Importantly, alternative splicing is a hallmark of cancer and a potential target for cancer therapeutics. Based on the statistical data, breast canc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Quan, Zhao, Jinyao, Zhang, Wenjing, Chen, Dan, Wang, Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884705/ https://www.ncbi.nlm.nih.gov/pubmed/31065692 http://dx.doi.org/10.1093/jmcb/mjz033

Ejemplares similares

Modulation of alternative splicing induced by paclitaxel in human lung cancer
por: Zhu, Ziran, et al.
Publicado: (2018)

Aberrant Alternative Splicing Is Another Hallmark of Cancer
por: Ladomery, Michael
Publicado: (2013)

Role of global aberrant alternative splicing events in papillary thyroid cancer prognosis
por: Lin, Peng, et al.
Publicado: (2019)

A summary of relationships between alternative splicing and breast cancer
por: Xiping, Zhang, et al.
Publicado: (2017)

Melatonin inhibits HCC progression through regulating the alternative splicing of NEMO
por: Bai, Lu, et al.
Publicado: (2022)

Given Dimensions of Neoplastic Events as Aberrantly Operative Alternative Splicing
por: Agius, Lawrence M.
Publicado: (2009)

SRSF1 modulates PTPMT1 alternative splicing to regulate lung cancer cell radioresistance
por: Sheng, Junxiu, et al.
Publicado: (2018)

Alternative splicing and the progesterone receptor in breast cancer
por: Cork, David MW, et al.
Publicado: (2008)

Signature of gene aberrant alternative splicing events in pancreatic adenocarcinoma prognosis
por: Yao, Jun, et al.
Publicado: (2021)

Novel Insights Into Triple-Negative Breast Cancer Prognosis by Comprehensive Characterization of Aberrant Alternative Splicing
por: Gong, Shasha, et al.
Publicado: (2020)

Contribution of alternative splicing to breast cancer metastasis
por: Meng, Xiangbing, et al.
Publicado: (2019)

Aberrant RNA Splicing in Cancer and Drug Resistance
por: Wang, Bi-Dar, et al.
Publicado: (2018)

Widespread alternative and aberrant splicing revealed by lariat sequencing
por: Stepankiw, Nicholas, et al.
Publicado: (2015)

Long-read sequencing reveals the landscape of aberrant alternative splicing and novel therapeutic target in colorectal cancer
por: Sun, Qiang, et al.
Publicado: (2023)

Regulation of RNA Splicing: Aberrant Splicing Regulation and Therapeutic Targets in Cancer
por: Kitamura, Koji, et al.
Publicado: (2021)

The prognostic significance of global aberrant alternative splicing in patients with myelodysplastic syndrome
por: Yang, Yi-Tsung, et al.
Publicado: (2018)

Aberrant Cyclin D1 splicing in cancer: from molecular mechanism to therapeutic modulation
por: Wang, Jing, et al.
Publicado: (2023)

Aberrant Bcl-x splicing in cancer: from molecular mechanism to therapeutic modulation
por: Dou, Zhihui, et al.
Publicado: (2021)

From General Aberrant Alternative Splicing in Cancers and Its Therapeutic Application to the Discovery of an Oncogenic DMTF1 Isoform
por: Tian, Na, et al.
Publicado: (2017)

Periostin Short Fragment with Exon 17 via Aberrant Alternative Splicing Is Required for Breast Cancer Growth and Metastasis
por: Ikeda-Iwabu, Yuka, et al.
Publicado: (2021)

Aberrant splicing and drug resistance in AML
por: de Necochea-Campion, Rosalia, et al.
Publicado: (2016)

Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer
por: Inoue, Kazushi, et al.
Publicado: (2015)

An exonic splicing enhancer mutation in DUOX2 causes aberrant alternative splicing and severe congenital hypothyroidism in Bama pigs
por: Cao, Chunwei, et al.
Publicado: (2019)

Alternative Splicing in Breast Cancer and the Potential Development of Therapeutic Tools
por: Martínez-Montiel, Nancy, et al.
Publicado: (2017)

Comprehensive analysis of aberrant alternative splicing related to carcinogenesis and prognosis of papillary thyroid cancer
por: Zheng, Xiaobo, et al.
Publicado: (2021)

Aberrant RNA splicing and therapeutic opportunities in cancers
por: Yamauchi, Hirofumi, et al.
Publicado: (2021)

Severe choline deficiency induces alternative splicing aberrance in optimized duck primary hepatocyte cultures
por: Zhao, Lulu, et al.
Publicado: (2022)

Alternative splicing and cancer: a systematic review
por: Zhang, Yuanjiao, et al.
Publicado: (2021)

Virus usurps alternative splicing to clear the decks for infection
por: Li, Ruixue, et al.
Publicado: (2023)

Signaling Pathways Driving Aberrant Splicing in Cancer Cells
por: Gonçalves, Vânia, et al.
Publicado: (2017)

Alternative Splicing for Diseases, Cancers, Drugs, and Databases
por: Tang, Jen-Yang, et al.
Publicado: (2013)

Significance of alternative splicing in cancer cells
por: Qi, Fei, et al.
Publicado: (2020)

Alternative Splicing in Plant Immunity
por: Yang, Shengming, et al.
Publicado: (2014)

Evolutionary Character of Alternative Splicing in Plants
por: Zhang, Chengjun, et al.
Publicado: (2016)

Diverse alternative back-splicing and alternative splicing landscape of circular RNAs
por: Zhang, Xiao-Ou, et al.
Publicado: (2016)

Serine/arginine-rich splicing factors: the bridge linking alternative splicing and cancer
por: Zheng, Xiang, et al.
Publicado: (2020)

Aberrant spliceosome expression and altered alternative splicing events correlate with maturation deficiency in human oocytes
por: Li, Junsheng, et al.
Publicado: (2020)

Splicing and alternative splicing in rice and humans
por: E, Zhiguo, et al.
Publicado: (2013)

E3 ubiquitin ligases: styles, structures and functions
por: Yang, Quan, et al.
Publicado: (2021)

Transcriptome sequencing of human breast cancer reveals aberrant intronic transcription in amplicons and dysregulation of alternative splicing with major therapeutic implications
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6lbcc8d48g82m1kcvordsbtlsp